MiMedx Group (NASDAQ:MDXG – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Monday. Other equities research analysts have also issued research reports about the stock. Lake Street Capital initiated coverage on shares of MiMedx Group in a research […]